Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Diabetes. 2016 Oct 7;9(7):689–698. doi: 10.1111/1753-0407.12477

Table 2. Odds ratios (95% confidence intervals) of type 2 diabetes associated with different levels of plasma lipid measures.

Variables Tertiles of lipid measures P for trend* R2 Per 1 SD increment

T1 T2 T3
HDL-C
 Cases/controls 294/191 195/190 82/190
 Model 1 1.00 0.67 (0.49-0.90) 0.27 (0.18-0.39) <0.001 10% 0.52 (0.44-0.62)
 Model 2 1.00 0.71 (0.51-0.98) 0.30 (0.20-0.44) <0.001 14% 0.55 (0.46-0.66)
 Model 3§ 1.00 0.82 (0.58-1.15) 0.47 (0.31-0.73) 0.001 18% 0.68 (0.56-0.82)
LDL-C
 Cases/controls 187/189 182/187 167/186
 Model 1 1.00 1.06 (0.76-1.47) 0.89 (0.60-1.30) 0.62 6% 1.03 (0.90-1.18)
 Model 2 1.00 1.07 (0.75-1.52) 0.87 (0.61-1.24) 0.43 11% 1.04 (0.91-1.20)
 Model 3§ 1.00 1.03 (0.70-1.52) 0.88 (0.60-1.29) 0.51 17% 1.08 (0.93-1.26)
TG
 Cases/controls 81/194 158/187 332/190
 Model 1 1.00 2.23 (1.52-3.28) 5.29 (3.56-7.88) <0.001 13% 2.09 (1.71-2.55)
 Model 2 1.00 2.15 (1.42-3.24) 5.21 (3.42-7.94) <0.001 17% 2.01 (1.65-2.46)
 Model 3§ 1.00 1.61 (1.04-2.50) 3.59 (2.30-5.61) <0.001 20% 1.70 (1.39-2.09)
TG/HDL-C ratio
 Cases/controls 69/191 171/190 331/190
 Model 1 1.00 2.51 (1.70-3.72) 5.35 (3.57-8.01) <0.001 13% 2.22 (1.79-2.77)
 Model 2 1.00 2.42 (1.59-3.66) 5.14 (3.36-7.89) <0.001 17% 2.14 (1.71-2.68)
 Model 3§ 1.00 1.87 (1.21-2.89) 3.31 (2.09-5.23) <0.001 19% 1.72 (1.37-2.17)

Abbreviations: R2, the coefficient of determination; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; TG/HDL-C ratio, the ratio of triglyceride to high-density lipoprotein cholesterol.

*

Linear trend was tested using the median level of each tertile of blood lipid profile.

Model 1: adjusted for age at blood taken (continuous), smoking (never, past, current smoker), alcohol intake (never, weekly or daily), weekly activity (<0.5, 0.5-3 hours/week, and ≥4 hours/week), education level (no, primary school, secondary or above), history of hypertension (yes, no), and fasting status (yes, no);

Model 2: Model 1 plus adjusted for body mass index (continuous);

§

Model 3: Model 2 plus adjusted for plasma concentrations of C-reactive protein (mmol/L) and adiponectin (μg/mL) (both in tertiles).